Finance

Lists
688302:SHA
Hinova Pharmaceuticals Inc
28,34 CN¥
-0,14%
(-0,040) 1D
16 қаз., 15:00:00 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688302...
Open
28,91 CN¥
High
29,55 CN¥
Low
28,06 CN¥
Mkt. cap
2,81 млрд
Avg. vol.
1,38 млн
Volume
1,41 млн
52-wk high
60,00 CN¥
52-wk low
28,06 CN¥
EPS
-1,33 CN¥
No. of employees
262
Open
28,91 CN¥
High
29,55 CN¥
Low
28,06 CN¥
Mkt. cap
2,81 млрд
Avg. vol.
1,38 млн
Volume
1,41 млн
52-wk high
60,00 CN¥
52-wk low
28,06 CN¥
EPS
-1,33 CN¥
No. of employees
262
News stories
From web sources and news partners
About Hinova Pharmaceuticals Inc
CEO-
Employees262
Founded2013 ж. 05 ақп.
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
10,18 млн
-2,88 млн
26,03 млн
28,95 млн
Cost of goods sold
38,34 мың
181,84 м.
47,44 мың
1,42 млн
Cost of revenue
38,34 мың
181,84 м.
47,44 мың
1,42 млн
Research and development expenses
31,80 млн
23,94 млн
29,38 млн
28,30 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
26,14 млн
22,09 млн
30,95 млн
30,10 млн
Operating expense
46,01 млн
58,31 млн
56,55 млн
62,86 млн
Total operating expenses
46,05 млн
58,49 млн
56,60 млн
64,27 млн
Operating income
-35,87 млн
-61,37 млн
-30,57 млн
-35,33 млн
Other non operating income
-404,74 м.
375,89 м.
-1,64 млн
1,57 млн
EBT including unusual items
-37,29 млн
-38,11 млн
-29,88 млн
-26,34 млн
EBT excluding unusual items
-32,71 млн
-58,81 млн
-30,42 млн
-35,11 млн
Income tax expense
1,03 мың
-9,00
3,13 мың
-26,00
Effective tax rate
-
-
-0,01%
-
Other operating expenses
-12,70 млн
13,16 млн
-3,92 млн
4,29 млн
Net income
-37,29 млн
-38,11 млн
-29,88 млн
-26,34 млн
Net profit margin
-366,18%
1 322,22%
-114,82%
-90,99%
Earnings per share
-
-
-
-
Interest and investment income
3,26 млн
3,91 млн
1,85 млн
2,04 млн
Interest expense
-84,08 мың
-74,98 мың
-65,61 мың
-64,23 мың
Net interest expenses
3,17 млн
3,83 млн
1,79 млн
1,97 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-35,35 млн
-60,33 млн
-29,53 млн
-33,40 млн
Gain or loss from assets sale
-
-
-
7,24 мың
AI content may include mistakes. Learn more
Google қолданбалары